目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Non-symmetric antacids - Market size and forecast 2021-2026
Exhibit 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
5.4 Symmetric antacids - Market size and forecast 2021-2026
Exhibit 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 Brazil - Market size and forecast 2021-2026
Exhibit 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AmerisourceBergen Corp.
Exhibit 85: AmerisourceBergen Corp. - Overview
Exhibit 86: AmerisourceBergen Corp. - Business segments
Exhibit 87: AmerisourceBergen Corp. - Key offerings
Exhibit 88: AmerisourceBergen Corp. - Segment focus
10.4 Bayer AG
Exhibit 89: Bayer AG - Overview
Exhibit 90: Bayer AG - Business segments
Exhibit 91: Bayer AG - Key offerings
Exhibit 92: Bayer AG - Segment focus
10.5 Cardinal Health Inc.
Exhibit 93: Cardinal Health Inc. - Overview
Exhibit 94: Cardinal Health Inc. - Business segments
Exhibit 95: Cardinal Health Inc. - Key news
Exhibit 96: Cardinal Health Inc. - Key offerings
Exhibit 97: Cardinal Health Inc. - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 98: GlaxoSmithKline Plc - Overview
Exhibit 99: GlaxoSmithKline Plc - Business segments
Exhibit 100: GlaxoSmithKline Plc - Key news
Exhibit 101: GlaxoSmithKline Plc - Key offerings
Exhibit 102: GlaxoSmithKline Plc - Segment focus
10.7 Humco Holding Group Inc.
Exhibit 103: Humco Holding Group Inc. - Overview
Exhibit 104: Humco Holding Group Inc. - Product / Service
Exhibit 105: Humco Holding Group Inc. - Key offerings
10.8 Johnson and Johnson
Exhibit 106: Johnson and Johnson - Overview
Exhibit 107: Johnson and Johnson - Business segments
Exhibit 108: Johnson and Johnson - Key news
Exhibit 109: Johnson and Johnson - Key offerings
Exhibit 110: Johnson and Johnson - Segment focus
10.9 Novartis AG
Exhibit 111: Novartis AG - Overview
Exhibit 112: Novartis AG - Business segments
Exhibit 113: Novartis AG - Key offerings
Exhibit 114: Novartis AG - Segment focus
10.10 Sanofi SA
Exhibit 115: Sanofi SA - Overview
Exhibit 116: Sanofi SA - Business segments
Exhibit 117: Sanofi SA - Key news
Exhibit 118: Sanofi SA - Key offerings
Exhibit 119: Sanofi SA - Segment focus
10.11 Sun Pharmaceutical Industries Ltd.
Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings
10.12 WellSpring Pharmaceutical Corp.
Exhibit 123: WellSpring Pharmaceutical Corp. - Overview
Exhibit 124: WellSpring Pharmaceutical Corp. - Product / Service
Exhibit 125: WellSpring Pharmaceutical Corp. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AmerisourceBergen Corp. - Overview
Exhibits86: AmerisourceBergen Corp. - Business segments
Exhibits87: AmerisourceBergen Corp. - Key offerings
Exhibits88: AmerisourceBergen Corp. - Segment focus
Exhibits89: Bayer AG - Overview
Exhibits90: Bayer AG - Business segments
Exhibits91: Bayer AG - Key offerings
Exhibits92: Bayer AG - Segment focus
Exhibits93: Cardinal Health Inc. - Overview
Exhibits94: Cardinal Health Inc. - Business segments
Exhibits95: Cardinal Health Inc. - Key news
Exhibits96: Cardinal Health Inc. - Key offerings
Exhibits97: Cardinal Health Inc. - Segment focus
Exhibits98: GlaxoSmithKline Plc - Overview
Exhibits99: GlaxoSmithKline Plc - Business segments
Exhibits100: GlaxoSmithKline Plc - Key news
Exhibits101: GlaxoSmithKline Plc - Key offerings
Exhibits102: GlaxoSmithKline Plc - Segment focus
Exhibits103: Humco Holding Group Inc. - Overview
Exhibits104: Humco Holding Group Inc. - Product / Service
Exhibits105: Humco Holding Group Inc. - Key offerings
Exhibits106: Johnson and Johnson - Overview
Exhibits107: Johnson and Johnson - Business segments
Exhibits108: Johnson and Johnson - Key news
Exhibits109: Johnson and Johnson - Key offerings
Exhibits110: Johnson and Johnson - Segment focus
Exhibits111: Novartis AG - Overview
Exhibits112: Novartis AG - Business segments
Exhibits113: Novartis AG - Key offerings
Exhibits114: Novartis AG - Segment focus
Exhibits115: Sanofi SA - Overview
Exhibits116: Sanofi SA - Business segments
Exhibits117: Sanofi SA - Key news
Exhibits118: Sanofi SA - Key offerings
Exhibits119: Sanofi SA - Segment focus
Exhibits120: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits121: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits122: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits123: WellSpring Pharmaceutical Corp. - Overview
Exhibits124: WellSpring Pharmaceutical Corp. - Product / Service
Exhibits125: WellSpring Pharmaceutical Corp. - Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations